Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. - Wikidata - wikimedia - TriplyDB

Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.

Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.

http://www.wikidata.org/entity/Q42084575

about

The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?Role of redoximiRs in fibrogenesis Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences Role of NADPH oxidases in the redox biology of liver fibrosis Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update Reactive oxygen species and fibrosis: further evidence of a significant liaison Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells The liver-specific tumor suppressor STAT5 controls expression of the reactive oxygen species-generating enzyme NOX4 and the proapoptotic proteins PUMA and BIM in mice.Evolving therapies for liver fibrosis.Role of NADPH oxidases in liver fibrosis.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).MicroRNA-21 Mediates Angiotensin II-Induced Liver Fibrosis by Activating NLRP3 Inflammasome/IL-1β Axis via Targeting Smad7 and Spry1.Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo.NADPH oxidase mediated oxidative stress in hepatic fibrogenesis Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth.Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.Liver Injury and the Activation of the Hepatic Myofibroblasts.Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice.Fatty acid-regulated transcription factors in the liver.NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease.Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme.Autophagy: a multifaceted partner in liver fibrosis.Antifibrotic therapies in the liver.NADPH Oxidases in Chronic Liver Diseases The rationale for targeting TGF-β in chronic liver diseases.Dysregulation of redox pathways in liver fibrosis.Reversal of liver cirrhosis: current evidence and expectations.Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis.Hepatic stellate cells as key target in liver fibrosis.Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.

P2860

Q26766479-E554C7E2-350C-49A6-9F6F-258F8B859891 Q26769973-9A59F733-81EC-4377-906C-F4538F8469C1 Q26776555-FBF077A9-F4E9-4A1D-B7F5-EBCC7063555D Q26786129-225BE12D-7074-43B5-ACAC-E29EC868F3E4 Q26800143-281DC46F-519B-4CD7-BB9E-D30829C8704D Q27027703-97307D6E-F33F-42BE-ADBB-EB8486A8BAF4 Q28077930-C1D0C58B-4B6A-4D02-98E3-680D77DFE1A9 Q28082065-6EA58BDB-7A45-4491-B42E-8BD6CEB67CA6 Q30369750-2B68CB3F-D527-4D5C-8494-D6C106171022 Q30528605-1104E856-F368-4083-8520-5FD11930D4C3 Q30539166-7DCDAB8D-7AAA-440C-9F40-33A1A965A2EE Q33632736-C9A43A1C-0A73-4797-AD30-32D1A5C985C2 Q33761211-D6AF0DAF-D625-447F-BE62-4AE3DFDBB34F Q33846263-B3E59604-9F4D-46C1-A38E-EA0E891CF6AB Q33900601-C027BFDB-C45D-40E4-B950-5C065F47CE0A Q33904328-B6FBE080-ECF7-4395-BE61-978D2A650D1A Q34276697-AEBB49F8-F7E9-47E9-B428-116BC33E7E2D Q34438060-CF382215-35D2-4D33-8BAD-91E3D01394EE Q34860956-3822C6BB-E736-45B4-887F-5772E3759969 Q35780859-F667FF97-A764-4553-9C5F-6E568E291443 Q35833225-D9566E2A-3E2A-405F-BA5F-ADAC07C842AA Q35893594-3A595339-5BB1-4173-A3B0-DA60461FF723 Q36026774-8E4365FA-2CD1-4C01-AAE5-FD7059CAA385 Q36521527-18D56E0B-E2E2-4EB7-AD65-2E04D4A34D95 Q36952084-9F5EDAA6-FF7A-4D04-83C3-9A4027DDC8FC Q37109402-CC41CDB0-2014-47FE-A1D7-503E8D3D394E Q37498674-0D7632D5-2EF0-45F2-A0AB-765A916C94E8 Q37613511-13BAE8A2-27CA-475C-8271-336B79BAA78C Q37739608-2147D0B7-1556-4032-A457-355123358D06 Q37863133-7F7B8229-F9C3-4BDC-A250-653901486079 Q37976066-CB934104-FF08-4584-8600-8462441C2832 Q38254156-2B9B1D57-C9D7-4B01-9A6A-263DA99C7520 Q38480164-608DCB0C-460D-482D-923B-EDB49B061363 Q38599090-B45E1D95-A013-4C8B-98A1-052147B071DB Q38715538-B6C9C3F4-B86B-4004-89A6-3DC14B8A5E00 Q38937340-9F675296-17C1-4741-BFCA-13E84CDD8EF6 Q38974002-5127249C-E72B-4159-804C-320E33C78F2A Q39707817-976DAECD-EF81-421E-9019-93DE3DF6491B Q40200602-B1F97E5E-E6CA-48E1-A34A-7D5AB9862B58 Q41547434-6F97CB94-14FD-4265-86CA-9F96AECF8A1B

P2860

Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.

http://www.wikidata.org/entity/Q42084575

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Reduced nicotinamide adenine d ...... nd liver fibrogenesis in vivo.

@en

Reduced nicotinamide adenine d ...... nd liver fibrogenesis in vivo.

@nl

type

label

Reduced nicotinamide adenine d ...... nd liver fibrogenesis in vivo.

@en

Reduced nicotinamide adenine d ...... nd liver fibrogenesis in vivo.

@nl

prefLabel

Reduced nicotinamide adenine d ...... nd liver fibrogenesis in vivo.

@en

Reduced nicotinamide adenine d ...... nd liver fibrogenesis in vivo.

@nl

P1433

Q42084575-0A66A696-BEE5-43EA-8197-2A2A473E0D91

P1476

Q42084575-10C06963-9583-4D9A-818B-098485DB0E41

P2093

Q42084575-0CD93EC5-BD1D-409E-BF03-71E1A108D785

Q42084575-2471C026-023A-4FFC-BD20-2BA620E8E9F5

Q42084575-2D5E04BF-BB8F-4010-B51C-3BC2A7F581F2

Q42084575-437615B2-D5D8-4F3A-B262-B536BE5FF738

Q42084575-8AC5E98D-71E2-493C-ADA5-ECCA90D01141

Q42084575-92306140-B0AB-4AB8-A405-4A292811C5C2

Q42084575-933B5931-989C-4CCC-949B-FE27C7EF1819

Q42084575-97602A12-2706-4BF8-BDD3-084F84EB94E0

Q42084575-B2B24A26-B784-4747-A001-0BAB43F35424

Q42084575-E3824591-A470-4854-81AF-6FE81BFBC6AF

P2860

Q42084575-05ED988B-C7A1-4191-8144-19172B716710

Q42084575-0F8EB0B7-58C3-4178-8DC5-6B218441ACDB

Q42084575-1717B287-1649-449E-AF64-A460C1568302

Q42084575-1813E57B-E3ED-4EB8-9A96-25C1C1862B43

Q42084575-1D8EDC05-BC06-4856-888B-F559BD050E21

Q42084575-1E5136CE-A2FC-4B79-BE26-C47E4E5EA1D7

Q42084575-3870EB9A-C8AD-47E8-8837-F3C839003E3F

Q42084575-5398D085-6595-4D46-BB99-A36F1C246F09

Q42084575-6720AC08-1229-4473-996C-0C9D09AE5CDD

Q42084575-6FB1D984-4D06-4AB6-A3DD-273FC660CB2D

P304

Q42084575-4106CC78-C713-4477-AFA2-F3C43EFD1799

P31

Q42084575-C9EF3DA5-D35C-4198-9E95-F92413450D1F

P356

Q42084575-4F14942E-8FAB-4E87-ABCA-8A0A89AF8E01

P407

Q42084575-F6AD79EF-86E4-4D6B-8C1E-8459ED26046E

P433

Q42084575-ABC509E4-03B9-4DE3-A7B2-74847ABBF914

P478

Q42084575-E04EB13F-499D-4953-83BE-D106D1210230

P50

Q42084575-9DA69E0F-1AF6-4600-AD46-929F316D6330

P577

Q42084575-53E2DC10-555B-4B0C-818A-7BE426A7F4CE

P5875

Q42084575-02D09833-4DCF-4B90-B33D-8A4E65C3D8F0

P698

Q42084575-12A5D10C-3DB1-43B7-8BD1-1F03F8F29B30

P932

Q42084575-0F34DC83-CA85-4ACB-A0D0-56894039045B

P356

J.GASTRO.2010.05.074

P1433

Gastroenterology

P1476

Reduced nicotinamide adenine d ...... nd liver fibrogenesis in vivo.

@en

P2093

Fiona Scott

http://www.w3.org/2001/XMLSchema#string

Joy X Jiang

http://www.w3.org/2001/XMLSchema#string

Natalie J Török

http://www.w3.org/2001/XMLSchema#string

Nobuko Serizawa

http://www.w3.org/2001/XMLSchema#string

Roger Adamson

http://www.w3.org/2001/XMLSchema#string

Scott L Friedman

http://www.w3.org/2001/XMLSchema#string

Senthil Venugopal

http://www.w3.org/2001/XMLSchema#string

Sridevi Devaraj

http://www.w3.org/2001/XMLSchema#string

Vijay Shah

http://www.w3.org/2001/XMLSchema#string

Xiangling Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2

Mechanisms of hepatic fibrogenesis

Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.

Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.

Innate apoptotic immunity: the calming touch of death.

Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8

Apoptotic cell removal.

Critical role of galectin-3 in phagocytosis by macrophages.

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells.

P304

1375-1384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2010.05.074

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

M. Eric Gershwin

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45504768

http://www.w3.org/2001/XMLSchema#string

P698

20685364

http://www.w3.org/2001/XMLSchema#string

P932

2949521

http://www.w3.org/2001/XMLSchema#string